Healthcare Global Enterprises Ltd

Health.Global Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Healthcare Global Enterprises Ltd

₹ 348 -0.34%
22 Jul 4:01 p.m.
hcgoncology.com BSE: 539787 NSE: HCG
About

Healthcare Global Enterprises Ltd is engaged in setting up and managing hospitals and medical diagnostic services including scientific testing and consultancy services in the pharmaceutical and medical sector.[1]

Key Points

Service Offering
The Company is a provider of specialty healthcare focused on cancer and fertility. Under the “HCG” brand, it operates the largest cancer care network in India in terms of the total number of private cancer treatment centers licensed by the AERB. It also provides fertility treatment under our “Milann” brand. [1]

Website BSE NSE
  • Market Cap ₹ 4,847 Cr.
  • Current Price ₹ 348
  • High / Low ₹ 401 / 310
  • Stock P/E 114
  • Book Value ₹ 85.3
  • Dividend Yield 0.00 %
  • ROCE 6.95 %
  • ROE 3.66 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has delivered good profit growth of 42.6% CAGR over last 5 years
  • Company's working capital requirements have reduced from 29.7 days to 20.2 days

Cons

  • Stock is trading at 4.08 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Company has a low return on equity of 3.02% over last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
179.51 200.60 215.66 215.51 220.19 243.17 253.07 252.68 258.67 272.23 282.75 267.21 280.38
156.39 169.73 178.27 175.20 179.76 197.21 206.35 203.06 218.69 224.69 232.34 220.48 225.53
Operating Profit 23.12 30.87 37.39 40.31 40.43 45.96 46.72 49.62 39.98 47.54 50.41 46.73 54.85
OPM % 12.88% 15.39% 17.34% 18.70% 18.36% 18.90% 18.46% 19.64% 15.46% 17.46% 17.83% 17.49% 19.56%
-139.75 4.53 126.96 -43.54 -24.75 1.87 1.27 2.10 0.56 1.83 2.13 5.52 -11.98
Interest 12.78 12.50 10.35 10.73 9.22 9.72 11.67 10.53 9.57 9.69 10.98 13.21 14.09
Depreciation 21.25 20.97 21.30 23.90 22.19 21.70 22.40 21.81 23.06 21.64 23.28 24.09 25.19
Profit before tax -150.66 1.93 132.70 -37.86 -15.73 16.41 13.92 19.38 7.91 18.04 18.28 14.95 3.59
Tax % 1.70% 27.46% 29.24% 3.35% 13.92% 33.88% 20.98% 26.93% 47.16% 24.11% 25.05% 44.28% 149.03%
-153.22 1.40 93.90 -39.13 -17.92 10.85 11.00 14.16 4.18 13.69 13.70 8.33 -1.76
EPS in Rs -12.22 0.11 7.49 -2.82 -1.29 0.78 0.79 1.02 0.30 0.98 0.98 0.60 -0.13
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
291 349 420 471 545 586 640 688 609 850 1,006 1,103
252 336 364 407 462 498 546 573 535 703 824 903
Operating Profit 39 13 56 64 83 88 94 116 74 147 181 200
OPM % 14% 4% 13% 14% 15% 15% 15% 17% 12% 17% 18% 18%
2 3 0 -1 7 19 13 -19 -129 65 7 -2
Interest 25 28 32 34 16 27 48 83 63 43 41 48
Depreciation 23 28 33 37 44 44 47 79 87 88 89 94
Profit before tax -7 -40 -8 -9 29 37 13 -65 -205 81 58 55
Tax % 9% -1% -69% -45% 34% 32% 42% -19% -7% 53% 30% 38%
-7 -40 -2 -5 19 25 7 -53 -192 38 40 34
EPS in Rs -1.05 -5.79 -0.34 -0.56 2.27 2.86 0.82 -6.01 -15.28 2.75 2.89 2.44
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 12%
5 Years: 11%
3 Years: 22%
TTM: 10%
Compounded Profit Growth
10 Years: 12%
5 Years: 43%
3 Years: 46%
TTM: -1%
Stock Price CAGR
10 Years: %
5 Years: 23%
3 Years: 16%
1 Year: 9%
Return on Equity
10 Years: 1%
5 Years: 1%
3 Years: 3%
Last Year: 4%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity Capital 67 68 70 85 86 87 88 89 125 139 139 139
Reserves 217 192 202 435 459 552 557 526 755 959 1,006 1,049
263 254 311 194 218 264 422 827 481 349 347 740
96 99 107 136 159 210 337 328 213 197 237 259
Total Liabilities 644 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,188
363 371 405 431 442 492 547 914 745 774 788 938
CWIP 1 10 28 29 33 79 104 44 28 5 9 36
Investments 138 80 84 155 141 219 299 316 366 439 475 506
142 152 173 235 306 322 454 495 436 426 458 707
Total Assets 644 614 690 850 923 1,112 1,404 1,769 1,575 1,644 1,730 2,188

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
24 34 51 58 54 66 87 86 71 124 130 195
-180 -7 -74 -86 -73 -185 -208 -116 -246 49 -138 -249
146 -19 22 120 -14 91 66 -3 236 -41 -42 105
Net Cash Flow -10 8 -1 92 -33 -27 -55 -32 61 132 -49 51

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 73 54 56 54 67 79 83 81 88 69 77 68
Inventory Days 33 33 36 30 36 40 39 31 32 30 33 31
Days Payable 181 191 208 266 257 269 253 247 214 167 168 197
Cash Conversion Cycle -75 -104 -116 -182 -154 -150 -131 -135 -94 -68 -59 -98
Working Capital Days 9 -33 -39 -46 -41 -23 -54 -72 105 30 39 20
ROCE % 4% -2% 5% 5% 6% 7% 6% 4% 1% 5% 7% 7%

Shareholding Pattern

Numbers in percentages

1 Recently
Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
68.40% 71.44% 71.43% 71.42% 71.39% 71.39% 71.37% 71.35% 71.30% 71.29% 71.28% 71.26%
7.24% 7.03% 6.99% 7.22% 7.27% 7.18% 6.37% 6.47% 6.29% 6.37% 6.74% 3.95%
8.16% 6.59% 5.86% 4.55% 4.02% 4.41% 5.53% 6.58% 7.94% 8.46% 8.52% 10.89%
16.19% 14.94% 15.73% 16.81% 17.32% 17.04% 16.71% 15.59% 14.49% 13.89% 13.45% 13.90%
No. of Shareholders 20,57322,36223,66323,01824,67228,70728,85825,93127,32727,28927,19526,529

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls